A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design

The Protein Data Bank

Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196

The Cambridge Structural Database: a quarter of a million crystal structures and rising

Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898

Interactions with Aromatic Rings in Chemical and Biological Recognition

Meyer, E. A., Castellano, R. K., & Diederich, F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390319 · Cited by 3,541

Frontier Orbitals and Organic Chemical Reactions

(1979) · Journal of Molecular Structure · doi:10.1016/0022-2860(79)80172-6 · Cited by 3,383

New software for searching the Cambridge Structural Database and visualizing crystal structures

Bruno, I. J., Cole, J. C., Edgington, P. R., Kessler, M., Macrae, C. F., McCabe, P., Pearson, J., & Taylor, R. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003324 · Cited by 3,126

Halogen bonding: the σ-hole: Proceedings of “Modeling interactions in biomolecules II”, Prague, September 5th–9th, 2005

Clark, T., Hennemann, M., Murray, J. S., & Politzer, P. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-006-0130-2 · Cited by 2,314

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076

Definition of the halogen bond (IUPAC Recommendations 2013).

Desiraju, G. R., Ho, P. S., Kloo, L., Legon, A. C., Marquardt, R., Metrangolo, P., Politzer, P., Resnati, G., & Rissanen, K. (2013) · Pure and Applied Chemistry · doi:10.1351/pac-rec-12-05-10 · Cited by 1,957

Halogen bonding and other σ-hole interactions: a perspective

Politzer, P., Murray, J. S., & Clark, T. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp00054k · Cited by 1,654

Halogen bonds in biological molecules

Auffinger, P., Hays, F. A., Westhof, E., & Ho, P. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407607101 · Cited by 1,634

Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery: Miniperspective

Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604

Halogen bonding: an electrostatically-driven highly directional noncovalent interaction

Politzer, P., Murray, J. S., & Clark, T. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c004189k · Cited by 1,580

Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures

Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,539

Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology

Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331

Discovery of N-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

Ditchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., & Taylor, S. S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208091 · Cited by 1,194

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128

Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation

Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., & Lesslauer, W. (1993) · Cell · doi:10.1016/0092-8674(93)90132-a · Cited by 1,104

2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products

Borthwick, A. D. (2012) · Chemical Reviews · doi:10.1021/cr200398y · Cited by 880

Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors

Lam, P. Y. S., Jadhav, P. K., Eyermann, C. J., Hodge, C. N., Ru, Y., Bacheler, L. T., Meek, J. L., Otto, M. J., Rayner, M. M., Wong, Y. N., et al. (1994) · Science · doi:10.1126/science.8278812 · Cited by 834

Elucidating the folding problem of helical peptides using empirical parameters

Muñoz, V., & Serrano, L. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0694-399 · Cited by 721

The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants

Tokarski, J. S., Newitt, J. A., Chang, C. Y. J., Cheng, J. D., Wittekind, M., Kiefer, S. E., Kish, K., Lee, F. Y. F., Borzillerri, R., Lombardo, L. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4187 · Cited by 700

Structure−Brain Exposure Relationships

Hitchcock, S. A., & Pennington, L. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060642i · Cited by 698

Thiopeptide Antibiotics

Bagley, M. C., Dale, J. W., Merritt, E. A., & Xiong, X. (2005) · Chemical Reviews · doi:10.1021/cr0300441 · Cited by 612

A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein−Protein Interaction

Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600

Intramolecular Hydrogen Bonding in Medicinal Chemistry

Kuhn, B., Mohr, P., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100087s · Cited by 571

Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?

Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563

Bleomycin: New Perspectives on the Mechanism of Action

Hecht, S. M. (2000) · Journal of Natural Products · doi:10.1021/np990549f · Cited by 559

Halogen Bonding—A Novel Interaction for Rational Drug Design?

Lu, Y., Shi, T., Wang, Y., Yang, H., Yan, X., Luo, X., Jiang, H., & Zhu, W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9000133 · Cited by 559

Systematic Investigation of Halogen Bonding in Protein–Ligand Interactions

Hardegger, L. A., Kuhn, B., Spinnler, B., Anselm, L., Ecabert, R., Stihle, M., Gsell, B., Thoma, R., Diez, J., Benz, J., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006781 · Cited by 492

Halogen bonding (X‐bonding): A biological perspective

Scholfield, M. R., Zanden, C. M. V., Carter, M., & Ho, P. S. (2013) · Protein Science · doi:10.1002/pro.2201 · Cited by 451

Controlling Conformations of Conjugated Polymers and Small Molecules: The Role of Nonbonding Interactions

Jackson, N. E., Savoie, B. M., Kohlstedt, K. L., Olvera de la Cruz, M., Schatz, G. C., Chen, L. X., & Ratner, M. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403667s · Cited by 444

Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5 S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor

Roehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K.-H., Reinemer, P., & Perzborn, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050101d · Cited by 436

Triggering Cell Death

Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., & de Vos, A. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80207-5 · Cited by 435

2-Aminothiazole as a Novel Kinase Inhibitor Template. Structure−Activity Relationship Studies toward the Discovery of N -(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a Potent pan -Src Kinase Inhibitor

Das, J., Chen, P., Norris, D., Padmanabha, R., Lin, J., Moquin, R. V., Shen, Z., Cook, L. S., Doweyko, A. M., Pitt, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060727j · Cited by 397

n→π* interactions in proteins

Bartlett, G. J., Choudhary, A., Raines, R. T., & Woolfson, D. N. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.406 · Cited by 389

The Practice of Medicinal Chemistry

(2015) · Elsevier eBooks · doi:10.1016/c2012-0-03066-9 · Cited by 383

Small Molecule Conformational Preferences Derived from Crystal Structure Data. A Medicinal Chemistry Focused Analysis

Brameld, K. A., Kuhn, B., Reuter, D. C., & Stahl, M. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7002494 · Cited by 372

The Methionine-aromatic Motif Plays a Unique Role in Stabilizing Protein Structure

Valley, C. C., Cembran, A., Perlmutter, J. D., Lewis, A. K., Labello, N. P., Gao, J., & Sachs, J. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374504 · Cited by 345

Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma

VanderMolen, K. M., McCulloch, W., Pearce, C. J., & Oberlies, N. H. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.35 · Cited by 333

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., & Misselwitz, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3185 · Cited by 297

Nature of Amide Carbonyl−Carbonyl Interactions in Proteins

Choudhary, A., Gandla, D., Krow, G. R., & Raines, R. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901188y · Cited by 286

The chemistry of activated bleomycin

Hecht, S. M. (1986) · Accounts of Chemical Research · doi:10.1021/ar00132a002 · Cited by 286

Chemical double-mutant cycles: dissecting non-covalent interactions

Cockroft, S. L., & Hunter, C. A. (2007) · Chem. Soc. Rev. · doi:10.1039/b603842p · Cited by 281

Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity

Matter, H., Nazaré, M., Güssregen, S., Will, D. W., Schreuder, H., Bauer, A., Urmann, M., Ritter, K., Wagner, M., & Wehner, V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806219 · Cited by 274

Intramolecular Nonbonded S···O Interaction Recognized in (Acylimino)thiadiazoline Derivatives as Angiotensin II Receptor Antagonists and Related Compounds

Nagao, Y., Hirata, T., Goto, S., Sano, S., Kakehi, A., Iizuka, K., & Shiro, M. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973109o · Cited by 271

Mitigating Heterocycle Metabolism in Drug Discovery

Jean, D. J. S., & Fotsch, C. H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300343m · Cited by 263

Treatment of Halogen Bonding in the OPLS-AA Force Field: Application to Potent Anti-HIV Agents

Jorgensen, W. L., & Schyman, P. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300180w · Cited by 262

Protein folding

Némethy, G., & Scheraga, H. A. (1977) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500002936 · Cited by 260

Nicotinic Acetylcholine Receptor Agonists: A Milestone for Modern Crop Protection

Jeschke, P., Nauen, R., & Beck, M. E. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302550 · Cited by 258

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors

Rheault, T. R., Stellwagen, J. C., Adjabeng, G. M., Hornberger, K. R., Petrov, K. G., Waterson, A. G., Dickerson, S. H., Mook, R. A., Laquerre, S. G., King, A. J., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000063 · Cited by 253

Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

Flygare, J. A., Beresini, M., Budha, N., Chan, H., Chan, I. T., Cheeti, S., Cohen, F., Deshayes, K., Doerner, K., Eckhardt, S. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300060k · Cited by 252

Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors

Ferreira, R. S., Simeonov, A., Jadhav, A., Eidam, O., Mott, B. T., Keiser, M. J., McKerrow, J. H., Maloney, D. J., Irwin, J. J., & Shoichet, B. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100488w · Cited by 247

Halogen Interactions in Protein–Ligand Complexes: Implications of Halogen Bonding for Rational Drug Design

Sirimulla, S., Bailey, J. B., Vegesna, R., & Narayan, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400257k · Cited by 243

Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding

Pierce, A. C., Sandretto, K. L., & Bemis, G. W. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10259 · Cited by 225

On the role of methionine residues in the sequence-independent recognition of nonpolar protein surfaces

Gellman, S. H. (1991) · Biochemistry · doi:10.1021/bi00241a001 · Cited by 223

Molecular mechanical study of halogen bonding in drug discovery

Ibrahim, M. A. A. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21836 · Cited by 223

Crystal Structure of a Soluble Form of the Intracellular Chloride Ion Channel CLIC1 (NCC27) at 1.4-Å Resolution

Harrop, S. J., DeMaere, M. Z., Fairlie, W. D., Reztsova, T., Valenzuela, S. M., Mazzanti, M., Tonini, R., Qiu, M. R., Jankova, L., Warton, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107804200 · Cited by 214

n→π* Interactions of Amides and Thioamides: Implications for Protein Stability

Newberry, R. W., VanVeller, B., Guzei, I. A., & Raines, R. T. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4033583 · Cited by 210

Discovery of a widely distributed toxin biosynthetic gene cluster

Lee, S. W., Mitchell, D. A., Markley, A. L., Hensler, M. E., Gonzalez, D., Wohlrab, A., Dorrestein, P. C., Nizet, V., & Dixon, J. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801338105 · Cited by 206

Minimization of polypeptide energy. I. Preliminary structures of bovine pancreatic ribonuclease S-peptide.

Gibson, K. D., & Scheraga, H. A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.2.420 · Cited by 197

Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3

Disch, J. S., Evindar, G., Chiu, C. H., Blum, C. A., Dai, H., Jin, L., Schuman, E., Lind, K. E., Belyanskaya, S. L., Deng, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400204k · Cited by 194

Models of S/π interactions in protein structures: Comparison of the H2S–benzene complex with PDB data

Ringer, A. L., Senenko, A., & Sherrill, C. D. (2007) · Protein Science · doi:10.1110/ps.073002307 · Cited by 192

Geometry of nonbonded interactions involving planar groups in proteins

Chakrabarti, P., & Bhattacharyya, R. (2007) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2007.03.016 · Cited by 192

Non-hydrogen Bond Interactions Involving the Methionine Sulfur Atom

Pal, D., & Chakrabarti, P. (2001) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2001.10506725 · Cited by 192

Structure and Spectroscopy of Oxyluciferin, the Light Emitter of the Firefly Bioluminescence

Naumov, P., Ozawa, Y., Ohkubo, K., & Fukuzumi, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904309q · Cited by 191

Photon‐Quantitative Reaction of a Dithiazolylarylene in Solution

Fukumoto, S., Nakashima, T., & Kawai, T. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006844 · Cited by 189

CHAINS OF ALTERNATING SULFUR AND π‐BONDED ATOMS IN EIGHT SMALL PROTEINS

Morgan, R. S., Tatsch, C. E., Gushard, R. H., Mcadon, J. M., & Warme, P. K. (1978) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1978.tb02841.x · Cited by 174

Cyclic HIV Protease Inhibitors: Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas

Lam, P. Y. S., Ru, Y., Jadhav, P. K., Aldrich, P. E., DeLucca, G. V., Eyermann, C. J., Chang, C.-H., Emmett, G., Holler, E. R., Daneker, W. F., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602571 · Cited by 173

Romidepsin: a novel histone deacetylase inhibitor for cancer

Bertino, E. M., & Otterson, G. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594437 · Cited by 166

Peptide-based inhibitors of the hepatitis C virus serine protease

Llinàs-Brunet, M., Bailey, M., Fazal, G., Goulet, S., Halmos, T., Laplante, S., Maurice, R., Poirier, M., Poupart, M.-A., Thibeault, D., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00299-6 · Cited by 161

Biologically Active Metabolites from Xenorhabdus Spp., Part 1. Dithiolopyrrolone Derivatives with Antibiotic Activity

McInerney, B. V., Gregson, R. P., Lacey, M. J., Akhurst, R. J., Lyons, G. R., Rhodes, S. H., Smith, D. R. J., Engelhardt, L. M., & White, A. H. (1991) · Journal of Natural Products · doi:10.1021/np50075a005 · Cited by 158

Control of Oxidation−Reduction Potentials in Flavodoxin from Clostridium beijerinckii: The Role of Conformation Changes,

Ludwig, M. L., Pattridge, K. A., Metzger, A. L., Dixon, M. M., Eren, M., Feng, Y., & Swenson, R. P. (1997) · Biochemistry · doi:10.1021/bi962180o · Cited by 158

Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases

Marcotte, D. J., Liu, Y., Arduini, R. M., Hession, C. A., Miatkowski, K., Wildes, C. P., Cullen, P. F., Hong, V. S., Hopkins, B. T., Mertsching, E., et al. (2010) · Protein Science · doi:10.1002/pro.321 · Cited by 158

Side-chain interactions between sulfur-containing amino acids and phenyalanine in .alpha.-helixes

Viguera, A. R., & Serrano, L. (1995) · Biochemistry · doi:10.1021/bi00027a028 · Cited by 155

The Neonicotinoid Electronegative Pharmacophore Plays the Crucial Role in the High Affinity and Selectivity for theDrosophilaNicotinic Receptor: An Anomaly for the Nicotinoid Cation−π Interaction Model

Tomizawa, M., Zhang, N., Durkin, K. A., Olmstead, M. M., & Casida, J. E. (2003) · Biochemistry · doi:10.1021/bi0300130 · Cited by 146

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase

Albrecht, B. K., Harmange, J.-C., Bauer, D., Berry, L., Bode, C., Boezio, A. A., Chen, A., Choquette, D. M., Dussault, I., Fridrich, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800043g · Cited by 143

Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc

Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., Robubi, A., & Rauh, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002928 · Cited by 142

2-Aminothiazoles as Therapeutic Leads for Prion Diseases

Gallardo‐Godoy, A., Gever, J. R., Fife, K. L., Silber, B. M., Prusiner, S. B., & Renslo, A. R. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101250y · Cited by 142

Hypervalent Nonbonded Interactions of a Divalent Sulfur Atom. Implications in Protein Architecture and the Functions

Iwaoka, M., & Isozumi, N. (2012) · Molecules · doi:10.3390/molecules17067266 · Cited by 138

Torsion Angle Preferences in Druglike Chemical Space: A Comprehensive Guide

Schärfer, C., Schulz‐Gasch, T., Ehrlich, H., Guba, W., Rarey, M., & Ståhl, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3016816 · Cited by 135

Energetics of an n → π* Interaction that Impacts Protein Structure

Hodges, J. A., & Raines, R. T. (2006) · Organic Letters · doi:10.1021/ol061569t · Cited by 133

Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole

Visser, F., Vickers, M. F., Ng, A. M. L., Baldwin, S. A., Young, J. D., & Cass, C. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105324200 · Cited by 130

Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib

Huang, Q., Johnson, T. W., Bailey, S., Brooun, A., Bunker, K. D., Burke, B. J., Collins, M. R., Cook, A. S., Cui, J. J., Dack, K. N., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401805h · Cited by 124

Bonding between nonbonded sulfur and oxygen atoms in selected organic molecules (a quantum chemical study)

Ángyán, J. G., Poirier, R. A., Kucsman, A., & Csizmadia, I. G. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00242a001 · Cited by 123

Functionally Important Aromatic–Aromatic and Sulfur−π Interactions in the D2 Dopamine Receptor

Daeffler, K. N.-M., Lester, H. A., & Dougherty, D. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304560x · Cited by 115

Estimates of the ab Initio Limit for Sulfur−π Interactions: The H2S−Benzene Dimer

Tauer, T. P., Derrick, M., & Sherrill, C. D. (2004) · The Journal of Physical Chemistry A · doi:10.1021/jp046778e · Cited by 111

Biosynthesis of some sulfur-containing natural products investigations of the mechanism of carbon-sulfur bond formation

Parry, R. J. (1983) · Tetrahedron · doi:10.1016/s0040-4020(01)91887-3 · Cited by 109

3-Heteroaryl-2-pyridones: Benzodiazepine Site Ligands with Functional Selectivity for α2/α3-Subtypes of Human GABAA Receptor-Ion Channels

Collins, I., Moyes, C. R., Davey, W. B., Rowley, M., Bromidge, F. A., Quirk, K., Atack, J. R., McKernan, R. M., THOMPSON, S., Wafford, K. A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110789 · Cited by 109

Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis

Shirude, P. S., Madhavapeddi, P., Naik, M., Murugan, K., Shinde, V. N., Nandishaiah, R., Bhat, J., Kumar, A., Hameed, S., Holdgate, G. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012033 · Cited by 108

Edoxaban

Camm, A. J., & Bounameaux, H. (2011) · Drugs · doi:10.2165/11595540-000000000-00000 · Cited by 107

Thiazolylaminomannosides As Potent Antiadhesives of Type 1 Piliated Escherichia coli Isolated from Crohn’s Disease Patients

Brument, S., Sivignon, A., Dumych, T. I., Moreau, N., Roos, G., Guérardel, Y., Chalopin, T., Deniaud, D., Bilyy, R. O., Darfeuille–Michaud, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400723n · Cited by 98

Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors

Flipo, M., Desroses, M., Lecat‐Guillet, N., Dirié, B., Carette, X., Leroux, F., Piveteau, C., Demirkaya, F., Lens, Z., Rucktooa, P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200076a · Cited by 95

Characterization of aromatic-thiol π-type hydrogen bonding and phenylalanine-cysteine side chain interactions throughab initiocalculations and protein database analyses

Duan, G., Smith, V. H., & Weaver, D. F. (2001) · Molecular Physics · doi:10.1080/00268970110063917 · Cited by 94

Lodopyridone, a Structurally Unprecedented Alkaloid from a Marine Actinomycete

Maloney, K. N., MacMillan, J. B., Kauffman, C. A., Jensen, P. R., DiPasquale, A. G., Rheingold, A. L., & Fenical, W. (2009) · Organic Letters · doi:10.1021/ol901997k · Cited by 94

Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogs. Synthesis, structure, and interactions with IMP dehydrogenase

Gebeyehu, G., Márquez, V. E., Cott, A. C. V., et al. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00379a018 · Cited by 93

Different Types of Interactions Involving Cysteine Sulfhydryl Group in Proteins

Pal, D., & Chakrabarti, P. (1998) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1998.10509001 · Cited by 93

Crystal Structures of Two Potent Nonamidine Inhibitors Bound to Factor Xa ,

Adler, M., Kochanny, M. J., Ye, B., Rumennik, G., Light, D. R., Biancalana, S., & Whitlow, M. D. (2002) · Biochemistry · doi:10.1021/bi0264061 · Cited by 93

Plantazolicin A and B: Structure Elucidation of Ribosomally Synthesized Thiazole/Oxazole Peptides from Bacillus amyloliquefaciens FZB42

Kalyon, B., Helaly, S. E., Scholz, R., Nachtigall, J., Vater, J., Borriss, R., & Süßmuth, R. D. (2011) · Organic Letters · doi:10.1021/ol200809m · Cited by 93

Addition of side chain interactions to modified Lifson‐Roig helix‐coil theory: Application to energetics of Phenylalanine‐Methionine interactions

Stapley, B. J., Rohl, C. A., & Doig, A. J. (1995) · Protein Science · doi:10.1002/pro.5560041117 · Cited by 91

Structure Determination and Interception of Biosynthetic Intermediates for the Plantazolicin Class of Highly Discriminating Antibiotics

Molohon, K. J., Melby, J. O., Lee, J., Evans, B. S., Dunbar, K. L., Bumpus, S. B., Kelleher, N. L., & Mitchell, D. A. (2011) · ACS Chemical Biology · doi:10.1021/cb200339d · Cited by 90

Epothilones as Lead Structures for the Synthesis-Based Discovery of New Chemotypes for Microtubule Stabilization

Feyen, F., Cachoux, F., Gertsch, J., Wartmann, M., & Altmann, K. (2007) · Accounts of Chemical Research · doi:10.1021/ar700157x · Cited by 90

Integrating Intramolecular Hydrogen Bonding (IMHB) Considerations in Drug Discovery Using ΔlogP As a Tool

Shalaeva, M. Y., Caron, G., Abramov, Y. A., O’Connell, T. N., Plummer, M. S., Yalamanchi, G., Farley, K. A., Goetz, G. H., Philippe, L., & Shapiro, M. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301850m · Cited by 89

Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases

Schönbrunn, E., Betzi, S., Alam, R., Martin, M. P., Becker, A., Han, H., Francis, R., Chakrasali, R., Jakkaraj, S., Kazi, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301234k · Cited by 88

Halogenated Benzenes Bound within a Non-polar Cavity in T4 Lysozyme Provide Examples of I⋯S and I⋯Se Halogen-bonding

Liu, L., Baase, W. A., & Matthews, B. W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.086 · Cited by 87

From nature to the laboratory and into the clinic

Nicolaou, K. C., Chen, J. S., & Dalby, S. M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.089 · Cited by 81

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors

Flipo, M., Desroses, M., Lecat‐Guillet, N., Villemagne, B., Blondiaux, N., Leroux, F., Piveteau, C., Mathys, V., Flament, M., Siepmann, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200825u · Cited by 80

Defining Cdk5 Ligand Chemical Space with Small Molecule Inhibitors of Tau Phosphorylation

Ahn, J. S., Radhakrishnan, M. L., Mapelli, M., Choi, S., Tidor, B., Cuny, G. D., Musacchio, A., Yeh, L.-A., & Kosik, K. S. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.05.011 · Cited by 79

Density Functional and Semiempirical Molecular Orbital Methods Including Dispersion Corrections for the Accurate Description of Noncovalent Interactions Involving Sulfur-Containing Molecules

Morgado, C. A., McNamara, J. P., Hillier, I. H., Burton, N. A., & Vincent, M. A. (2007) · Journal of Chemical Theory and Computation · doi:10.1021/ct700072a · Cited by 78

PREDICTOR FOR SULFUR‐AROMATIC INTERACTIONS IN GLOBULAR PROTEINS

Morgan, R. S., & Mcadon, J. M. (1980) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1980.tb02566.x · Cited by 77

Design and Synthesis of Novel DFG-Out RAF/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors. 1. Exploration of [5,6]-Fused Bicyclic Scaffolds

Okaniwa, M., Hirose, M., Imada, T., Ohashi, T., Hayashi, Y., Miyazaki, T., Arita, T., Yabuki, M., Kakoi, K., Kato, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300126x · Cited by 75

Synthesis and Conformational Analysis of a Non-Amidine Factor Xa Inhibitor That Incorporates 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine as S4 Binding Element

Haginoya, N., Kobayashi, S., Komoriya, S., Yoshino, T., Suzuki, M., Shimada, T., Watanabe, K., Hirokawa, Y., Furugori, T., & Nagahara, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049884d · Cited by 72

Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines

Lam, T., Hilgers, M. T., Cunningham, M. L., Kwan, B. P., Nelson, K. J., Brown‐Driver, V., Ong, V. S., Trzoss, M., Hough, G., Shaw, K. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401204g · Cited by 72

Inhibitors of proteases and amide hydrolases that employ an α-ketoheterocycle as a key enabling functionality

Maryanoff, B. E., & Costanzo, M. J. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.015 · Cited by 71

[1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt Pathway That Inhibit Tankyrases 1 and 2 via Novel Adenosine Pocket Binding

Shultz, M. D., Kirby, C. A., Stams, T., Chin, D. N., Blank, J., Charlat, O., Cheng, H., Cheung, A. K., Cong, F., Feng, Y., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2011222 · Cited by 69

Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State

Williams, N. K., Lucet, I. S., Klinken, S. P., Ingley, E., & Rossjohn, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807850200 · Cited by 68

Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors

Alam, M., Beevers, R. E., Ceska, T., Davenport, R. J., Dickson, K. M., Fortunato, M., Gowers, L., Haughan, A. F., James, L. A., Jones, M. W., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.078 · Cited by 62

Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel

Bilodeau, M. T., Balitza, A. E., Koester, T. J., Manley, P. J., Rodman, L. D., Buser‐Doepner, C., Coll, K. E., Fernandes, C., Gibbs, W. W., Heimbrook, D. C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049697f · Cited by 61

Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors

Boezio, A. A., Berry, L., Albrecht, B. K., Bauer, D., Bellon, S. F., Bode, C., Chen, A., Choquette, D. M., Dussault, I., Hirai, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.096 · Cited by 60

2‐Anilinobenzamides as SIRT Inhibitors

Suzuki, T., Imai, K., Nakagawa, H., & Miyata, N. (2006) · ChemMedChem · doi:10.1002/cmdc.200600162 · Cited by 60

Structural Studies of a Potent Insect Maturation Inhibitor Bound to the Juvenile Hormone Esterase ofManduca sexta,

Wogulis, M. D., Wheelock, C. E., Kamita, S. G., Hinton, A. C., Whetstone, P. A., Hammock, B. D., & Wilson, D. K. (2006) · Biochemistry · doi:10.1021/bi0521644 · Cited by 58

Two Poly(2,5-thienythiazolothiazole)s: Observation of Spontaneous Ordering in Thin Films

Naraso, & Wudl, F. (2008) · Macromolecules · doi:10.1021/ma071857k · Cited by 57

Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure

Kerekes, A. D., Esposite, S. J., Doll, R. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1010995 · Cited by 57

Principal Components Describing Biological Activities and Molecular Diversity of Heterocyclic Aromatic Ring Fragments

GIBSON, S. G., McGuire, R., & Rees, D. C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960058h · Cited by 54

Design, Synthesis, and Biological Evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic Acids as New Indole-Based Cytosolic Phospholipase A2α Inhibitors

Tomoo, T., Nakatsuka, T., Katayama, T., Hayashi, Y., Fujieda, Y., Terakawa, M., & Nagahira, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500494y · Cited by 53

Potent s-cis-Locked Bithiazole Correctors of ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Cellular Processing for Cystic Fibrosis Therapy

Yu, G., Yoo, C. L., Yang, B., Lodewyk, M. W., Meng, L., El‐Idreesy, T. T., Fettinger, J. C., Tantillo, D. J., Verkman, A. S., & Kurth, M. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800533c · Cited by 51

Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)

Haynes, N.-E., Corbett, W. L., Bizzarro, F. T., Guertin, K. R., Hilliard, D. W., Holland, G. W., Kester, R. F., Mahaney, P. E., Qi, L., Spence, C. L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100039a · Cited by 49

Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease

LaPlante, S. R., Nar, H., Lemke, C. T., Jakalian, A., Aubry, N., & Kawai, S. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401338c · Cited by 46

Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors

Hua, Z., Bregman, H. S., Buchanan, J. L., Chakka, N., Guzmán-Pérez, A., Günaydin, H., Huang, X. Y., Gu, Y., Berry, V. M., Liu, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401317z · Cited by 46

Synthesis and Structure Activity Relationship Studies of Benzothieno[3,2-b]furan Derivatives as a Novel Class of IKK.BETA. Inhibitors

Sugiyama, H., Yoshida, M., Mori, K., Kawamoto, T., Sogabe, S., Takagi, T., Oki, H., Tanaka, T., Kimura, H., & Ikeura, Y. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.613 · Cited by 46

4′-Methyl-4,5′-bithiazole-based correctors of defective ΔF508-CFTR cellular processing

Yoo, C. L., Yu, G., Yang, B., Robins, L. I., Verkman, A. S., & Kurth, M. J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.037 · Cited by 45

Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode

Huang, X., Cheng, C. C., Fischmann, T. O., Duca, J. S., Yang, X., Richards, M. P., & Shipps, G. W. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200249h · Cited by 43

Strong interaction between disulfide derivatives and aromatic groups in peptides and proteins

Némethy, G., & Scheraga, H. A. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)90865-2 · Cited by 43

Potency and Selectivity of Trifluoroacetylimino and Pyrazinoylimino Nicotinic Insecticides and Their Fit at a Unique Binding Site Niche

Tomizawa, M., Kagabu, S., Ohno, I., Durkin, K. A., & Casida, J. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800191a · Cited by 43

Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors

Vogt, D., Weber, J., Ihlefeld, K., Brüggerhoff, A., Proschak, E., & Stark, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.044 · Cited by 43

Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration

Probst, G. D., Bowers, S., Sealy, J. M., Truong, A. P., Hom, R. K., Galemmo, R. A., Konradi, A. W., Sham, H. L., Quincy, D. A., Pan, H., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.010 · Cited by 43

Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors

Belanger, D., Curran, P. J., Hruza, A. W., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.008 · Cited by 42

NMR study of 1:1 complexes between divalent sulfur and aromatic compounds: A model for interactions in globular proteins

Bodner, B. L., Jackman, L. M., & Morgan, R. S. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91306-6 · Cited by 41

Sulfur-Containing Natural Products from Marine Invertebrates

Prinsep, M. R. (2003) · Studies in natural products chemistry · doi:10.1016/s1572-5995(03)80151-5 · Cited by 40

Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors

Suzuki, T., Imai, K., Imai, E., Iida, S., Ueda, R., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.001 · Cited by 39

Deorphaning Pyrrolopyrazines as Potent Multi‐Target Antimalarial Agents

Reker, D., Seet, M., Pillong, M., Koch, C. P., Schneider, P., Witschel, M. C., Rottmann, M., Freymond, C., Brun, R., Schweizer, W. B., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311162 · Cited by 39

Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors

Huang, X., Cheng, C. C., Fischmann, T. O., Duca, J. S., Richards, M. P., Tadikonda, P. K., Reddy, P. A., Zhao, L., Siddiqui, M. A., Parry, D., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.108 · Cited by 38

2-Acylimino-3H-thiazoline derivatives: A novel template for platelet GPIIb/IIIa receptor antagonists

Manaka, A., Sato, M., Aoki, M., Tanaka, M., Ikeda, T., Toda, Y., Yamane, Y., & Nakaike, S. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00123-8 · Cited by 37

Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core

Yu, T., Tagat, J. R., Kerekes, A. D., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100063w · Cited by 36

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase

Bilodeau, M. T., Rodman, L. D., McGaughey, G. B., Coll, K. E., Koester, T. J., Hoffman, W. F., Hungate, R. W., Kendall, R. L., McFall, R. C., Rickert, K. W., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.052 · Cited by 36

Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors

Lin, S., Wrobleski, S. T., Hynes, J. J., Pitt, S., Zhang, R., Fan, Y., Doweyko, A. M., Kish, K., Sack, J. S., Malley, M. F., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.102 · Cited by 35

Why is Firefly Oxyluciferin a Notoriously Labile Substance?

Maltsev, O. V., Nath, N. K., Naumov, P., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307972 · Cited by 35

Nocodazole is a High‐Affinity Ligand for the Cancer‐Related Kinases ABL, c‐KIT, BRAF, and MEK

Park, H., Hong, S., Hong, S., Hong, S., & Hong, S. (2011) · ChemMedChem · doi:10.1002/cmdc.201100410 · Cited by 34

Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice

Silber, B. M., Rao, S., Fife, K. L., Gallardo‐Godoy, A., Renslo, A. R., Dalvie, D., Giles, K., Freyman, Y., Elepano, M., Gever, J. R., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0912-4 · Cited by 33

Identification of a New Class of Glucokinase Activators through Structure-Based Design

Hinklin, R. J., Boyd, S. A., Chicarelli, M. J., Condroski, K. R., DeWolf, W. E., Lee, P. A., Lee, W., Singh, A., Thomas, L., Voegtli, W. C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401116k · Cited by 33

Design, synthesis and SAR of novel glucokinase activators

Cheruvallath, Z. S., Gwaltney, S. L., Sabat, M. P., Tang, M., Feng, J., Wang, H., Miura, J., Guntupalli, P., Jennings, A. J., Hosfield, D. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.093 · Cited by 32

Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases

Ghaemmaghami, S., Russo, M. M., & Renslo, A. R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5001425 · Cited by 31

Efficient organocatalytic α-sulfenylation of substituted piperazine-2,5-diones

Dubey, R., Polaske, N. W., Nichol, G. S., & Olenyuk, B. Z. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.05.031 · Cited by 31

Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092

Waring, M. J., Johnstone, C., McKerrecher, D., Pike, K. G., & Robb, G. R. (2011) · MedChemComm · doi:10.1039/c1md00092f · Cited by 31

Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors

Laha, J. K., Zhang, X., Qiao, L., Liu, M., Chatterjee, S., Robinson, S. D., Kosik, K. S., & Cuny, G. D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.140 · Cited by 30

Identification of potent 5-pyrimidinyl-2-aminothiazole CDK4, 6 inhibitors with significant selectivity over CDK1, 2, 5, 7, and 9

Shimamura, T., Shibata, J., Kurihara, H., Mita, T., Otsuki, S., Sagara, T., Hirai, H., & Iwasawa, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.048 · Cited by 30

X‐Ray Crystal Structure of Bone Marrow Kinase in the X Chromosome: A Tec Family Kinase

Muckelbauer, J. K., Sack, J. S., Ahmed, N., Burke, J. R., Chang, C. Y., Gao, M., Tino, J. A., Xie, D., & Tebben, A. J. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01230.x · Cited by 29

Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics

Hornberger, K. R., Chen, X., Crew, A. P. A., Kleinberg, A., Ma, L., Mulvihill, M. J., Wang, J., Wilde, V. L., Albertella, M. R., Bittner, M., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.054 · Cited by 28

Crystal Structure of the Ligand Binding Domain of Netrin G2

Brasch, J., Harrison, O. J., Ahlsén, G., Liu, Q., & Shapiro, L. S. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.10.030 · Cited by 27

Mechanism and Site of Inhibition of AMPA Receptors: Pairing a Thiadiazole with a 2,3-Benzodiazepine Scaffold

Wang, C., Han, Y., Wu, A., Sólyom, S., & Niu, L. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400193u · Cited by 27

Chapter 3 Applications of the NOE in Molecular Biology

Williamson, M. P. (2009) · Annual reports on NMR spectroscopy · doi:10.1016/s0066-4103(08)00203-2 · Cited by 25

Remarkable discrepancy in the predominant structures of acyl(or thioacyl)aminothiadiazoles, acyl(or thioacyl)aminooxadiazoles and related compounds having the potential for rotational, geometrical and tautomeric isomerism

Nagao, Y., Iimori, H., Goto, S., Hirata, T., Sano, S., Chuman, H., & Shiro, M. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(02)00080-1 · Cited by 24

Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates

Dudkin, V., Rickert, K. W., Kreatsoulas, C., Wang, C., Arrington, K. L., Fraley, M. E., Hartman, G. D., Yan, Y., Ikuta, M., Stirdivant, S. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.110 · Cited by 23

Intramolecular Nonbonded S...N Interaction in Rabeprazole

Hayashi, K., Ogawa, S., Sano, S., Shiro, M., Yamaguchi, K., Sei, Y., & Nagao, Y. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.802 · Cited by 23

Crystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state

Farenc, C., Celie, P. H. N., Tensen, C. P., de Esch, I. J. P., & Siegal, G. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.028 · Cited by 22

Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Oka, Y., Yabuuchi, T., Oi, T., Kuroda, S., Fujii, Y., Ohtake, H., Inoue, T., Wakahara, S., Kimura, K., Fujita, K., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.042 · Cited by 21

Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking

Coffman, K. C., Nguyen, H. H., Phuan, P.-W., Hudson, B. M., Yu, G., Bagdasarian, A. L., Montgomery, D., Lodewyk, M. W., Yang, B., Yoo, C. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5007885 · Cited by 21

2‐Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease

Li, Z., Silber, B. M., Rao, S., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300007 · Cited by 20

Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonists

Hirata, T., Nomiyama, J., Sakae, N., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00250-8 · Cited by 20

N-Haloacetylimino neonicotinoids: Potency and molecular recognition at the insect nicotinic receptor

Tomizawa, M., Durkin, K. A., Ohno, I., Nagura, K., Manabe, M., Kumazawa, S., & Kagabu, S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.107 · Cited by 17

Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms

Haidle, A. M., Zabierek, A. A., Childers, K. K., Rosenstein, C., Mathur, A., Altman, M. D., Chan, G. H., Xu, L. S., Bachman, E. S., Mo, J.-R., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.064 · Cited by 12

Identification through structure-based methods of a bacterial NAD+-dependent DNA ligase inhibitor that avoids known resistance mutations

Murphy-Benenato, K. E., Wang, H., McGuire, H. M., Davis, H. E., Gao, N., Prince, D. B., Jahić, H., Stokes, S. S., & Boriack‐Sjodin, P. A. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.007 · Cited by 12

Chemical Pharma-Sciences that Incorporate Non-Covalent Bonded Interactions

Nagao, Y. (2012) · Heterocycles · doi:10.3987/rev-12-756 · Cited by 11

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815

Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design

Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710